Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Where next for gefitinib in patients with lung cancer?
Blackhall F, Ranson M, Thatcher N. Blackhall F, et al. Among authors: thatcher n. Lancet Oncol. 2006 Jun;7(6):499-507. doi: 10.1016/S1470-2045(06)70725-2. Lancet Oncol. 2006. PMID: 16750500 Review.
Gefitinib for the treatment of non-small-cell lung cancer.
Campbell L, Blackhall F, Thatcher N. Campbell L, et al. Among authors: thatcher n. Expert Opin Pharmacother. 2010 Jun;11(8):1343-57. doi: 10.1517/14656566.2010.481283. Expert Opin Pharmacother. 2010. PMID: 20426712 Review.
Chemotherapy in non-small cell lung cancer.
Thatcher N, Ranson M, Lee SM, Niven R, Anderson H. Thatcher N, et al. Ann Oncol. 1995;6 Suppl 1:83-94; discussion 94-5. doi: 10.1093/annonc/6.suppl_1.s83. Ann Oncol. 1995. PMID: 8695551 Review.
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer.
Baka S, Ashcroft L, Anderson H, Lind M, Burt P, Stout R, Dowd I, Smith D, Lorigan P, Thatcher N. Baka S, et al. Among authors: thatcher n. J Clin Oncol. 2005 Apr 1;23(10):2136-44. doi: 10.1200/JCO.2005.01.003. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15713598 Clinical Trial.
Management of small-cell lung cancer.
Thatcher N, Faivre-Finn C, Lorigan P. Thatcher N, et al. Ann Oncol. 2005;16 Suppl 2:ii235-9. doi: 10.1093/annonc/mdi700. Ann Oncol. 2005. PMID: 15958464 Free article. Review. No abstract available.
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).
Booton R, Lorigan P, Anderson H, Baka S, Ashcroft L, Nicolson M, O'Brien M, Dunlop D, O'Byrne K, Laurence V, Snee M, Dark G, Thatcher N. Booton R, et al. Among authors: thatcher n. Ann Oncol. 2006 Jul;17(7):1111-9. doi: 10.1093/annonc/mdl078. Epub 2006 Apr 7. Ann Oncol. 2006. PMID: 16603599 Free article. Clinical Trial.
391 results